INTRODUCTION
The styryl lactone goniothalamin (1) is a secondary metabolite distributed among the plants of the genus Goniothalamus which has cytotoxic and antiproliferative properties. 1, 2 Given the interest of our research group to pursue studies of the biological activity of compounds based on its structure, we proposed the synthesis of hydrophilic analogs (2a-c).
Moreover, the incorporation of fluorine into molecules has become a common tool in medicinal chemistry for improving the pharmacological profile of bioactive compounds.
3-5 Thus, we proposed the synthesis of compounds (2d-e) containing the trifluoromethyl groups. 
RESULTS AND DISCUSSION
The general synthetic route to achieve analogs 2a-e is represented in Scheme 1. The synthesis of lactones 2a-e began with the preparation of aldehydes 7a-e. Reagent 4 was used to homologate commercial aldehydes 3a-e by the HWE reaction, followed by reduction of esters 5a-e with DIBAL-H and oxidation with IBX, leading to the corresponding aldehydes 7a-e. The hydroxyl groups were protected using TBSCl and DIPEA.
Allyl Grignard was added to generate the homoallylic alcohols which were reacted with acryloyl chloride leading to the corresponding esters. Finally, the lactone analogs were achieved by treating the dienes with Grubbs I catalyst (5 mol%). The TBS groups were removed using solution of HF in pyridine. The overall yields are summarized in Table 1 . 
CONCLUSION
The present work discloses the synthesis of five novel lactone analogs (2a-e) of goniothalamin. These compounds will be evaluated in vitro against human tumor cell lines in an antiproliferative assay and also for the inhibition of protein phosphatase.
